India taking several steps to reduce dependence on imports of API

Domestic drug manufacturers has seen a sharp spike in the prices of these raw materials after the Chinese government shut down many API producing plants owing to environmental concerns

India is taking several steps to reduce its dependence on imports of active pharmaceutical ingredients (APIs), a commonly used raw material for drugs, by manufacturing it within the country.
 
Domestic drug manufacturers, which mostly import APIs from China, has seen a sharp spike in the prices of these raw materials after the Chinese government shut down many API producing plants owing to environmental concerns. This had prompted pharmaceutical lobby group to demand for hike in prices of medicines that are currently under the price control.
 
“We want to promote API production in India under the Make in India'